Literature DB >> 17223864

A classification of psoriasis vulgaris according to phenotype.

C E M Griffiths1, E Christophers, J N W N Barker, R J G Chalmers, S Chimenti, G G Krueger, C Leonardi, A Menter, J-P Ortonne, L Fry.   

Abstract

For nearly 200 years it has been appreciated that plaque psoriasis consists of a number of distinct clinical phenotypes. However, a reliable and simple stratification of clinical presentation of psoriasis is lacking. In the era of immunogenetic association studies and an advanced understanding of the pathomechanisms of psoriasis it is important that a classification of the disease according to phenotype is readily available. Such a classification would facilitate clinically relevant interpretation of investigational data. A meeting of the International Psoriasis Council produced a consensus on clinical phenotypes of psoriasis equally relevant to clinical practitioners and psoriasis researchers.

Entities:  

Mesh:

Year:  2007        PMID: 17223864     DOI: 10.1111/j.1365-2133.2006.07675.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  46 in total

1.  Antimicrobial peptide LL-37 along with peptidoglycan drive monocyte polarization toward CD14(high)CD16(+) subset and may play a crucial role in the pathogenesis of psoriasis guttata.

Authors:  Lei Qian; Wei Chen; Wen Sun; Ming Li; Renshan Zheng; Qing Qian; Lianzheng Lv
Journal:  Am J Transl Res       Date:  2015-06-15       Impact factor: 4.060

2.  Pharmacogenetic markers to predict the clinical response to methotrexate in south Indian Tamil patients with psoriasis.

Authors:  S Indhumathi; Medha Rajappa; Laxmisha Chandrashekar; P H Ananthanarayanan; D M Thappa; V S Negi
Journal:  Eur J Clin Pharmacol       Date:  2017-04-25       Impact factor: 2.953

3.  Cutaneous microdialysis: cytokine evidence for altered innate reactivity in the skin of psoriasis patients?

Authors:  Florence Sjögren; Karin Davidsson; Michael Sjöström; Chris D Anderson
Journal:  AAPS J       Date:  2012-02-29       Impact factor: 4.009

4.  Association of C-Reactive Protein (rs1205) Gene Polymorphism with Susceptibility to Psoriasis in South Indian Tamils.

Authors:  Anjana Sudhesan; Medha Rajappa; Laxmisha Chandrashekar; Palghat Hariharan Ananthanarayanan; Devinder Mohan Thappa; Santhosh Satheesh; Adithan Chandrasekaran; Panneer Devaraju
Journal:  J Clin Diagn Res       Date:  2016-10-01

5.  CARD14 alterations in Tunisian patients with psoriasis and further characterization in European cohorts.

Authors:  M Ammar; C T Jordan; L Cao; E Lim; C Bouchlaka Souissi; A Jrad; I Omrane; S Kouidhi; I Zaraa; H Anbunathan; M Mokni; N Doss; E Guttman-Yassky; A B El Gaaied; A Menter; A M Bowcock
Journal:  Br J Dermatol       Date:  2015-11-17       Impact factor: 9.302

Review 6.  Current and emerging systemic treatment strategies for psoriasis.

Authors:  Philip M Laws; Helen S Young
Journal:  Drugs       Date:  2012-10-01       Impact factor: 9.546

7.  Prevalence of psoriasis phenotypes among men and women in the USA.

Authors:  J F Merola; T Li; W-Q Li; E Cho; A A Qureshi
Journal:  Clin Exp Dermatol       Date:  2016-02-18       Impact factor: 3.470

8.  Update of the management of chronic psoriasis: new approaches and emerging treatment options.

Authors:  Philip M Laws; Helen S Young
Journal:  Clin Cosmet Investig Dermatol       Date:  2010-04-21

Review 9.  Psoriasis.

Authors:  Paola Di Meglio; Federica Villanova; Frank O Nestle
Journal:  Cold Spring Harb Perspect Med       Date:  2014-08-01       Impact factor: 6.915

Review 10.  Treatment recommendations for psoriatic arthritis.

Authors:  C T Ritchlin; A Kavanaugh; D D Gladman; P J Mease; P Helliwell; W-H Boehncke; K de Vlam; D Fiorentino; O Fitzgerald; A B Gottlieb; N J McHugh; P Nash; A A Qureshi; E R Soriano; W J Taylor
Journal:  Ann Rheum Dis       Date:  2008-10-24       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.